Molecular Diagnostics Market Future Scope Demands and Projected Industry Growths to 2028 Global Market Insights added a report on Global Molecular Diagnostics Market that provide in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region. Get sample copy of this research report @ https://www.gminsights.com/requestsample/detail/434 The molecular diagnostics market is projected to exhibit considerable development by 2028 due to recent technological advances in disease diagnosis across the globe. Molecular diagnostics have been the center point in the screening, treatment, control, isolation, and prevention of COVID-19 owing to their accurate and rapid results. In addition, in case of a novel pathogen, such as the SARS-CoV-2, molecular diagnostics is more reliable as it targets the proteome or genome of the pathogen, thereby giving a clear picture of the genomic composition and the nature of the pathogen. Prevalent adoption of RT-PCR tests to detect the novel coronavirus has augmented industry uptake during the pandemic. The molecular diagnostics market has been segmented on the basis of end-use, product, application, technology, and region. In terms of product, the market has been divided into reagents & kits and instruments. The reagents & kits sub-segment was valued at around USD 38.2 billion in 2021 and is speculated to expand at a sturdy pace through the review timeline. This growth is attributed to the rising prevalence of genetic disorders around the world. Moreover, favorable government initiatives and increasing R&D investments are likely to fuel segmental expansion over the forthcoming years. From the technology perspective, the molecular diagnostics market has been categorized into microarrays, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, sequencing, and others. In 2021, the sequencing subsegment held a market share of nearly 2% and is set to witness optimistic growth over the study period. Growing incidences of cancer, along with surging use of NGS in several applications, are estimated to propel market adoption. Based on application, the market has been segregated into genetic disease testing, infectious disease diagnostics, oncology testing, and others. The molecular diagnostics market from the infectious diseases diagnostics sub-segment recorded a valuation of almost USD 47 billion in 2021 and is anticipated to showcase a solid growth trajectory over 2022-2028. Mounting incidences of infectious diseases and rising awareness among people regarding disease diagnostics treatment in developing countries are projected to accelerate segmental demand. Partial Table of Contents (ToC) of the report: Chapter 4 Molecular Diagnostics Market, By Product © 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com